银杏达莫注射液治疗急性脑梗死

Clinical Effect of Observation of Ginkgo Injection in Treatment of Acute Cerebral Infarction

目的:探讨银杏达莫注射液在治疗急性脑梗死中的疗效。方法:急性脑梗死(ACI)患者分为治疗组(92例)、对照组(80例)。治疗组患者在常规治疗(脱水、扩容药物治疗,以及常规阿司匹林、胞二磷胆碱等药物)基础上应用银杏达莫注射液25 mL,加250 mL的0.9%NaCl,静脉滴注,1次/d;对照组在常规治疗基础上联合丹红注射液30 mL/次,1次/d,两组患者药物治疗疗程均为14 d。结果:联合银杏达莫注射液治疗组患者的总有效率为94.6%,明显优于对照组的83.8%(P<0.05)。治疗后治疗组Batthel指数(MBI)评分(84.5±17.7),简式Fugl-Meyer评定法(FMA)评分(92.5±14.3)分,均显著高于对照组治疗后的(72.5±14.3),(84.6±11.9)分(P<0.05)。结论:银杏达莫注射液治疗急性脑梗死的临床效果理想,安全性较高。

Objective：To analyze ginkgo dipyridamole injection in the treatment of patients with acute cerebral infarction.Method：Via treated acute cerebral infarction patients with foundation treatment based on application of dipyridamole injection,we compared the treatment effect for the documented application traditional treatment combined with Dan hong injection treatment of acute cerebral infarction.Result： The patients with treatment of joint ginkgo injection,the total effective rate was 94.6%,which was significantly higher than the 83.8% in the control group（P0.05）.The average score after treatment MBI was（84.5±17.7）,FMA score average（92.5±14.3）,were significantly higher than those in the control group treated（72.5 ±14.3）,（84.6±11.9）（P 0.05）.Conclusion：Ginkgo dipyridamole injection in treatment of acute cerebral infarction had an ideal,safety effect.